1-(cyclobutylamino)-4-[3-(4-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]pyrrole-2-carboxylic acid
C20H18FN3O4 — CID 174562725
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(cyclobutylamino)-4-[3-(4-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]pyrrole-2-carboxylic acid
1-(cyclobutylamino)-4-[3-(4-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]pyrrole-2-carboxylic acid (PubChem CID 174562725) has the molecular formula C20H18FN3O4 and a molecular weight of 383.38 g/mol. Its IUPAC name is 1-(cyclobutylamino)-4-[3-(4-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]pyrrole-2-carboxylic acid.
Molecular Properties
| Compound Name | 1-(cyclobutylamino)-4-[3-(4-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]pyrrole-2-carboxylic acid |
|---|---|
| PubChem CID | 174562725 |
| Molecular Formula | C20H18FN3O4 |
| Molecular Weight | 383.38 g/mol |
| Exact Mass | 383.13 |
| IUPAC Name | 1-(cyclobutylamino)-4-[3-(4-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]pyrrole-2-carboxylic acid |
| SMILES | Cc1onc(-c2ccc(F)cc2)c1C(=O)c1cc(C(=O)O)n(NC2CCC2)c1 |
| InChI | InChI=1S/C20H18FN3O4/c1-11-17(18(23-28-11)12-5-7-14(21)8-6-12)19(25)13-9-16(20(26)27)24(10-13)22-15-3-2-4-15/h5-10,15,22H,2-4H2,1H3,(H,26,27) |
| InChIKey | CLSWUJHEWCPDSH-UHFFFAOYSA-N |
| XLogP | 3.62 |
| TPSA | 97.36 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 383.38 |
| LogP ≤ 5 | 3.62 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 174562725 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.